Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals     Biopharmaceuticals    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Global Biosimilars Market Research Report

  • Report Code: BI 1000
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount
Biosimilars and Chromatography, E-Clinical Trial Solutions, Wireless Health, Immunoassay, Digital Pathology, Next Generation Sequencing (NGS) and NGS Platforms/Consumables/Services adds up to total Biopharmaceuticals market.

Biosimilars can be segmented by Applications, Geographies, Companies and Submarkets. Applications of this market are Oncology, Blood Disorders , Auto-immune Diseases, Infectious disease and Growth Hormone Deficiency. Geographies of this market are North America, Europe, Asia-Pacific and Rest of World. Companies of this market are Sandoz, Teva Pharmaceuticals, Inc (cephalon) and Hospira, Inc.. Submarkets of this market are Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins and Recombinant Peptides.

 

Key Questions Answered

  • What are market estimates and forecasts; which of Biosimilars markets are doing well and which are not?
  • What is the competitive landscape; How companies like Sandoz, Teva Pharmaceuticals, Inc (cephalon) and Hospira, Inc. doing in Biosimilars?
  •  

    What makes our report unique?

    • This reports provides most granular segmentation on Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins and Recombinant Peptides.
    • It will provide you market insights into Oncology, Blood Disorders , Auto-immune Diseases and Infectious disease.
    • This report provides market sizing and forecast for the Biosimilars market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
    • The report provides deep dive competitive landscape covering the top players such as Sandoz, Teva Pharmaceuticals, Inc (cephalon) and Hospira, Inc..
    • The reports provides benchmarking insight on the top players Sandoz, Teva Pharmaceuticals, Inc (cephalon) and Hospira, Inc..
    • The report provide competitive intelligence on Sandoz, Teva Pharmaceuticals, Inc (cephalon) and Hospira, Inc..
    • Many times, customers do not get specific intelligence they are looking for in multi-client syndicated studies. So we offer 10% customization which will ensure you get the desired market intelligence, may it be specific to Oncology, Blood Disorders , Auto-immune Diseases and Infectious disease applications or Biosimilars market in North America, Europe, Asia-Pacific and Rest of World.
    •  

      Audience for this report

      • Global Biosimilars companies
      • Manufacturing Companies
      • Traders, distributors, and suppliers
      • Governmental and research organizations
      • Associations and industry bodies
      • Technology providers


1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Submarkets
4.1 Recombinant Non-Glycosylated Proteins
4.2 Recombinant Glycosylated Proteins
4.3 Recombinant Peptides
5 By Applications
5.1 Oncology
5.2 Blood Disorders 
5.3 Auto-immune Diseases
5.4 Infectious disease
5.5 Growth Hormone Deficiency
6 By Geographies
6.1 North America
6.2 Europe
6.3 Asia-Pacific
6.4 Rest of World
7 By Companies
7.1 Sandoz
7.2 Teva Pharmaceuticals, Inc (cephalon)
7.3 Hospira, Inc.

Please fill in the form below to receive a free copy of the Summary of this Report
















Global Biosimilars Market Research Report

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Recombinant Non-Glycosylated Proteins Recombinant Non-Glycosylated Proteins
Recombinant Non-Glycosylated Proteins and Recombinant Glycosylated Proteins and
Upcoming
Recombinant Glycosylated Proteins Recombinant Glycosylated Proteins
Recombinant Glycosylated Proteins and Recombinant Non-Glycosylated Proteins and
Upcoming
Recombinant Peptides Recombinant Peptides
Recombinant Peptides and Recombinant Non-Glycosylated Proteins and
Upcoming
Insulin Insulin
Insulin and Recombinant Human Growth Hormone (RHGH),
Upcoming
Recombinant Human Growth Hormone (RHGH) Recombinant Human Growth Hormone (RHGH)
Recombinant Human Growth Hormone (RHGH) and Insulin,
Upcoming
Granulocyte Colony-Stimulating Factor (Filgrastim) Granulocyte Colony-Stimulating Factor (Filgrastim)
Granulocyte Colony-Stimulating Factor (Filgrastim) and Insulin,
Upcoming
Interferon Biosimilars Interferon Biosimilars
Interferon Biosimilars and Insulin, Recombinant Human...
Upcoming
Erythropoietin (EPO) Erythropoietin (EPO)
Erythropoietin (EPO) and Monoclonal Antibodies (MAB) and
Upcoming
Monoclonal Antibodies (MAB) Monoclonal Antibodies (MAB)
Monoclonal Antibodies (MAB) and Erythropoietin (EPO) and
Upcoming
Follitropin Follitropin
Follitropin and Erythropoietin (EPO) and Monoclonal...
Upcoming
Glucagon Glucagon
Glucagon and Calcitonin adds up to total Recombinant Peptides...
Upcoming
Calcitonin Calcitonin
Calcitonin and Glucagon adds up to total Recombinant Peptides...
Upcoming
12 of 12 items
12 reports | Show
Connect With Us
US/CAN : +1-888-502-0539